| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.51 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |